-
Mashup Score: 29
TikTok points researcher toward signal of benefit
Source: www.medpagetoday.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Patient Phenotypes Within the Clinical Program of an IL-23 Inhibitor for PsA | RheumNow - 11 day(s) ago
Watch rheumatologist Dr. Alexis Ogdie and rheumatologist and dermatologist Dr. Saakshi Khattri discuss a new analysis of patient phenotypes in PsA from clinical trials of an IL-23 inhibitor. In this conversation, they discuss disease activity differences between clinical trial populations and real-world patients, efficacy of an IL-23 inhibitor in a bionaïve, moderate PsA phenotype, and the IL-23 inhibitor’s potential role in managing patients with PsA.
Source: rheumnow.comCategories: General Medicine NewsTweet
-
Mashup Score: 28
TikTok points researcher toward signal of benefit
Source: www.medpagetoday.comCategories: General Medicine NewsTweet
-
Mashup Score: 16Dr. John Cush - 14 day(s) ago
EULAR 2025 – SpA Panel Discussion
Source: twitter.comCategories: General Medicine NewsTweet
-
Mashup Score: 6Long-term maintenance of response of an IL-23i in PsA | RheumNow - 14 day(s) agoSource: rheumnow.comCategories: General Medicine News, RheumatologyTweet
-
Mashup Score: 2Patient Phenotypes Within the Clinical Program of an IL-23 Inhibitor for PsA | RheumNow - 14 day(s) ago
Watch rheumatologist Dr. Alexis Ogdie and rheumatologist and dermatologist Dr. Saakshi Khattri discuss a new analysis of patient phenotypes in PsA from clinical trials of an IL-23 inhibitor. In this conversation, they discuss disease activity differences between clinical trial populations and real-world patients, efficacy of an IL-23 inhibitor in a bionaïve, moderate PsA phenotype, and the IL-23 inhibitor’s potential role in managing patients with PsA.
Source: rheumnow.comCategories: General Medicine NewsTweet
-
Mashup Score: 2Daily Eular 2025 Recap Day 3 | RheumNow - 15 day(s) ago
Catch up on the biggest breakthroughs, standout sessions, and expert insights from the third day of EULAR 2025. Join us live as we break down the key highlights and what they mean for the future of rheumatology.
Source: rheumnow.comCategories: General Medicine NewsTweet
-
Mashup Score: 8Dr. John Cush - 15 day(s) ago
EULAR 2025 – PsA Panel Discussion
Source: twitter.comCategories: General Medicine NewsTweet
-
Mashup Score: 21Dr. John Cush - 16 day(s) ago
EULAR 2025 – RA Panel Discussion
Source: twitter.comCategories: General Medicine NewsTweet
-
Mashup Score: 38
A TriNetX EHR study shows that psoriatic arthritis, but not psoriasis, patients are at increased risk for interstitial lung disease (ILD).
Source: rheumnow.comCategories: General Medicine NewsTweet
#EULAR2025 TriNetX database study indicated that fibromyalgia patients who used glucagon-like peptide-1 (GLP-1) receptor agonist drugs were less likely to use opioids and to report pain, fatigue, and malaise compared with propensity-matched non-users https://t.co/ftm93VwW65 https://t.co/GpC7QliKXH